Orphan Drugs Market Insights, Forecast to 2025
Verfasser: riyasharma24mr on Wednesday, 26 June 2019An orphan drug is a pharmaceutical agent that has been developed specifically to treat a rare medical condition, the condition itself being referred to as an orphan disease.
High unmet needs are one of the primary drivers of market growth. The need for the development of effective drugs with lesser side-effects is rapidly rising in the market.
Moreover, the initiatives from the governments of various countries across the globe towards R&D activities and numerous marketing approvals of these drugs have also influenced the orphan drugs market growth. Furthermore, the rising occurrences of rare diseases with the mounting awareness among the population and larger life expectancy numbers have accelerated the global orphan drug market to grow higher.
Report Sample includes:
- Table of Contents
- List of Tables & Figures
- Charts
- Research Methodology
Get FREE Sample of this Report at https://www.24marketreports.com/report-sample/global-orphan-drugs-2025-556
The global Orphan Drugs market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Orphan Drugs market based on company, product type, end user and key regions.